Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
63.62
-1.36 (-2.09%)
Nov 20, 2026, 4:00 PM EST - Market closed
Corcept Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,963 | 3,661 | 5,280 | 3,348 | 2,186 | 2,097 | |
Market Cap Growth | -13.02% | -30.67% | 57.69% | 53.13% | 4.24% | -30.98% |
Enterprise Value | 6,309 | 3,143 | 4,739 | 2,933 | 1,787 | 1,603 |
Last Close Price | 63.62 | 34.80 | 50.39 | 32.48 | 20.31 | 19.80 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 47.86 | 37.29 | 37.78 | 31.74 | 21.59 | 18.64 |
Forward PE | 14.38 | 55.53 | 32.11 | 32.61 | 19.95 | 21.01 |
PS Ratio | 7.23 | 4.81 | 7.82 | 6.94 | 5.44 | 5.73 |
PB Ratio | 8.35 | 5.65 | 7.77 | 6.61 | 4.36 | 5.58 |
P/TBV Ratio | 8.35 | 5.65 | 7.77 | 6.61 | 4.36 | 5.58 |
P/FCF Ratio | 35.78 | 25.82 | 26.92 | 26.46 | 18.23 | 12.53 |
P/OCF Ratio | 35.15 | 25.78 | 26.63 | 26.43 | 18.17 | 12.49 |
PEG Ratio | - | 1.96 | 1.96 | 1.96 | 1.96 | 1.50 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.55 | 4.13 | 7.02 | 6.08 | 4.45 | 4.38 |
EV/EBITDA Ratio | 55.77 | 68.40 | 34.40 | 27.08 | 15.69 | 12.73 |
EV/EBIT Ratio | 56.89 | 70.15 | 34.60 | 27.34 | 15.87 | 12.88 |
EV/FCF Ratio | 32.42 | 22.17 | 24.16 | 23.18 | 14.90 | 9.58 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.08 | 0.13 | 0.05 | 0.00 | 0.01 | 0.00 |
Debt / FCF Ratio | 0.05 | 0.04 | 0.04 | 0.00 | 0.01 | 0.00 |
Net Debt / Equity Ratio | -0.78 | -0.81 | -0.88 | -0.84 | -0.87 | -0.89 |
Net Debt / EBITDA Ratio | -5.77 | -11.45 | -4.33 | -3.93 | -3.82 | -2.66 |
Net Debt / FCF Ratio | -3.36 | -3.71 | -3.04 | -3.36 | -3.63 | -2.00 |
Asset Turnover | 1.04 | 0.91 | 0.92 | 0.80 | 0.80 | 0.74 |
Inventory Turnover | 1.16 | 1.03 | 1.08 | 0.94 | 0.97 | 1.07 |
Quick Ratio | 2.71 | 2.60 | 3.11 | 4.05 | 6.60 | 5.31 |
Current Ratio | 3.01 | 2.92 | 3.35 | 4.39 | 6.89 | 5.61 |
Return on Equity (ROE) | 22.15% | 15.02% | 23.81% | 21.05% | 23.11% | 25.03% |
Return on Assets (ROA) | 17.16% | 11.71% | 19.11% | 17.51% | 20.11% | 22.60% |
Return on Invested Capital (ROIC) | 25.24% | 15.32% | 54.21% | 87.09% | 87.74% | 94.15% |
Return on Capital Employed (ROCE) | 13.00% | 6.70% | 19.60% | 20.80% | 22.00% | 33.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.09% | 2.72% | 2.67% | 3.17% | 4.64% | 5.36% |
FCF Yield | 2.80% | 3.87% | 3.72% | 3.78% | 5.48% | 7.98% |
Buyback Yield / Dilution | 0.19% | -5.73% | -1.55% | 3.64% | 7.94% | -1.42% |